ART Outcomes in Endometriosis and Adenomyosis Patients.pdf

TevfikYoldemirMDBBAM 15 views 59 slides Mar 07, 2025
Slide 1
Slide 1 of 59
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59

About This Presentation

ART outcomes for women with endometriosis, adenomyosis, and both


Slide Content

ART Outcomes
Endometriosis & Adenomyosis
Tevfik Yoldemir MD, BSc, MA, PhD
[email protected]
profdr.tevfikyoldemir
Co-chair of the Council of Affiliated Menopause Societies- CAMS
Associate Editor of Climacteric, Gynecological Endocrinology,
European Gynecology and Obsterics
Full Professor of Obs & Gyn @ Marmara University, Istanbul

I have no financial relationships to disclose.

Key confounders in different steps of the IVF procedure
Reproductive Biology and
Endocrinology (2023) 21:107
doi.10.1186/s12958-023-01157-8

Ovarian response
Egg retrieval
Fertilization
Implantation

Endometriosis and live birth
Human Fertility, DOI: 10.1080/14647273.2023.2200979

Impact of moderate-to-severe endometriosis on IVF
cumulative live birth rate
RBMO VOLUME 47 ISSUE 3 2023 103186
doi:10.1016/j.rbmo.2023.02.012

Live birth rate - Women with and without Endometriosis
J Gynecol Obstet Hum Reprod 51 (2022) 102446

Journal of Assisted Reproduction
and Genetics (2019) 36:1649–1656
doi.10.1007/s10815-019-01519-5
Endometriosis
OSI which refers to the number of
oocytes retrieved for
gonadotrophins administered is a
measure of ovarian responsiveness.

Journal of Assisted Reproduction
and Genetics (2019) 36:1649–1656
doi.10.1007/s10815-019-01519-5
Endometrioma

Cumulative live birth rate after fresh and frozen IVF cycles
with single embryo transfer
Journal of Assisted Reproduction and Genetics (2019) 36:1649–1656
doi.10.1007/s10815-019-01519-5

N=4416

Conventional IVF performs similarly in women
with and without endometriosis
Journal of Assisted Reproduction
and Genetics (2023) 40:599–607
doi.10.1007/s10815-022-02700-z

IVF/ICSI outcomes in the endometrioma and control groups
Journal of Ovarian Research (2022) 15:116
doi.10.1186/s13048-022-01042-9



The matched
variables included
maternal age,
maternal BMI, and
duration of infertility

2067 patients undergoing their first IVF/ICSI cycles with autologous oocytes

Journal of Ovarian Research (2022) 15:116
doi.10.1186/s13048-022-01042-9



Endometriosis patients with and without prior surgery

Unoperated OMAs according to the cyst size


Journal of Ovarian Research (2022) 15:116
doi.10.1186/s13048-022-01042-9

Cumulative pregnancy rate in women with current,
resected, or recurred endometrioma
Taiwanese Journal of Obstetrics & Gynecology 62 (2023) 677-681
Doi: 10.1016/j.tjog.2023.07.008

qualitative and quantitative assessment of
ovarian response and embryo development
RBMO VOLUME 45 ISSUE 2 2022
doi:10.1016/j.rbmo.2022.04.010

qualitative and quantitative assessment of
ovarian response and embryo development
RBMO VOLUME 45 ISSUE 2 2022
doi:10.1016/j.rbmo.2022.04.010

Fertility Outcomes of
Freeze-All vs. Fresh Embryo Transfer
endometriosis by laparoscopy and
classified stage III to IV according to
the revised ASRM scoring system
Front. Endocrinol. 10:770.
doi: 10.3389/fendo.2019.00770
16 covariates:
age,
BMI,
duration of infertility,
gravidity,
parity,
endocrinological profile (basal
FSH, LH, E2, P, and AFC),
concomitant infertility factors
(tubal factors and male factors),
procedure,
number of oocytes retrieved,
number of embryos available,
number of embryos transferred

Fertility Outcomes of
Freeze-All vs. Fresh Embryo Transfer
the number of oocytes retrieved
Front. Endocrinol. 10:770.
doi: 10.3389/fendo.2019.00770
endometriosis by laparoscopy and
classified stage III to IV according to
the revised American Society for
Reproductive Medicine (ASRM)
scoring system

deferred embryo transfer strategy
PLoS ONE 14(8): e0220256.
doi.10.1371/journal.pone.0194800

Endometrial receptivity in women with endometriosis
FET cycles
RBMO VOLUME 47 ISSUE 6 2023
doi.10.1016/j.rbmo.2023.103414
N=101
N=101

Endometriosis and oocyte quality
donor oocyte recipients vs autologous
Human Reproduction Open, pp. 1–8, 2022
doi.10.1093/hropen/hoac025
women with endometriosis undergoing
758 donor oocyte recipient were compared
with 12856 autologous IVF cycles
Live birth outcomes- fresh and frozen
*Adjustment for confounders (number of previous IVF cycles, previous live birth, period of treatment, day of embryo transfer,
number of embryo transferred, fresh and frozen cycle for combined fresh/frozen).
*Adjustment for confounders (number of previous IVF cycles, previous live birth, year of treatment, day of embryo transfer, number
of embryo transferred, fresh and frozen cycle for combined fresh/frozen).

Live Birth After Oocyte Donation In Vitro Fertilization
Cycles in Women With Endometriosis
JAMA Network Open. 2024;7(1):e2354249.
doi:10.1001/jamanetworkopen.2023.54249

Live Birth After Oocyte Donation IVF Cycles in Women With
Endometriosis
JAMA Network Open. 2024;7(1):e2354249.
doi:10.1001/jamanetworkopen.2023.54249

Oocyte donation outcomes in endometriosis with multiple failures
RBMO VOLUME 47 ISSUE 2 2023 103236
10.1016/j.rbmo.2023.05.008

Outcomes of IVF/ICSI-FET in studies about Endometriosis.
Front. Endocrinol. 2020;11:427.
doi: 10.3389/fendo.2020.00427

Outcomes of FET in the Endometriosis subgroups.
Front. Endocrinol. 2020;11:427.
doi: 10.3389/fendo.2020.00427

Single frozen-thawed embryo transfer
after preimplantation genetic testing
Journal of Assisted Reproduction and Genetics (2024) 41:429–435
doi.10.1007/s10815-023-02996-5

Clinical outcomes per vitrified-warmed euploid
single blastocyst transfer
European Journal of Obstetrics & Gynecology and
Reproductive Biology 256 (2021) 205–210
doi.10.1016/j.ejogrb.2020.11.024

Patients affected from endometriosis (n = 210)
Controls (n = 420)
ICSI with qPCR and trophectoderm biopsy-based
PGT-A

Cumulative live birth delivery rates (CLBdR)
among completed cycles
European Journal of Obstetrics &
Gynecology and Reproductive
Biology 256 (2021) 205–210
doi.10.1016/j.ejogrb.2020.11.024

Patients affected from endometriosis (n = 210)
Controls (n = 420)
ICSI with qPCR and trophectoderm biopsy-based
PGT-A

Patients with endometriosis have aneuploidy rates
equivalent to their age-matched peers


Fertil Steril 2017 Aug;108(2):284-288.
doi: 10.1016/j.fertnstert.2017.05.038.

Oocyte Cryopreservation in Women with Ovarian
Endometriosis
J. Clin. Med. 2023,12,6767. doi.10.3390/jcm12216767

Oocyte vitrification for fertility preservation in women
with endometriosis
The number of oocytes retrieved and the number of MII oocytes finally vitrified, calculated
per cycle and per patient, was higher in women with no ovarian surgery before FP (P<.05).

The numbers were similar when we compared between surgically treated patients (unilateral
vs. bilateral surgery; not statistically significant [NS]).

Embryo quality was similar between the groups (NS).

The survival rate and CLBR were comparable in the three groups (NS).
Fertil Steril 2020;113:836–44.
doi:10.1016/j.fertnstert.2019.11.017

Oocyte vitrification for fertility preservation in women
with endometriosis
Fertil Steril 2020;113:836–44.
doi:10.1016/j.fertnstert.2019.11.017
Among patients aged %35 years, Surgery did not affect the survival rate (NS).

Similarly, the CLBR was statistically significantly higher in the nonsurgical group
(72.5%) compared with the group of patients who underwent surgery (52.8%).

Live birth rate in women without and with adenomyosis
Reproductive Sciences (2022) 29:3177–3193
doi.10.1007/s43032-021-00818-6
40% reduction in LBR

Comparisons of Live Birth Rate between the adenomyosis
and non-adenomyosis populations
BMJ Open 2024;14:e077025.
doi:10.1136/bmjopen-2023-077025
35% reduction in LBR

Reproductive outcomes calculated per fresh ET cycle.
Front. Endocrinol. 13:865358.
doi: 10.3389/fendo.2022.865358

Pregnancy outcomes after frozen–thawed embryo transfer
Archives of Gynecology and Obstetrics (2021) 304:1089–1096
doi. 10.1007/s00404-021-06011-z

Subgroup comparisons of LBR with Fresh ET between the
adenomyosis and non-adenomyosis populations
BMJ Open 2024;14:e077025.
doi:10.1136/bmjopen-2023-077025
The first subgroup received long-acting GnRHa pretreatment (ultralong protocol).
The second subgroup received non-GnRHa pretreatment (long/antagonist/short
protocols).
The LBR was 30.82% (470/1525) in the adenomyosis and
52.13% (1956/3752) in the non-adenomyosis groups
LBR of adenomyosis group was very poor (24.07% vs 50.82%)

Subgroup comparisons of LBR with FET protocols between the
adenomyosis and non- adenomyosis populations
BMJ Open 2024;14:e077025.
doi:10.1136/bmjopen-2023-077025
The third subgroup assessed the effect of long-acting GnRHa pretreatment.
The fourth subgroup assessed the effect of non-GnRHa pretreatment
(long/antagonist/short protocols) on FET cycles.

Comparisons of LBR with long acting GnRHa vs nonGnRHa in the
adenomyosis population
BMJ Open 2024;14:e077025.
doi:10.1136/bmjopen-2023-077025
Following sensitivity analysis, we observed that the LBR in the long-acting GnRHa group was
higher than that in the non-long GnRHa group (seven studies, 2009 women, 42.54% vs 30.20%,
OR: 0.08, 95% CI: 0.03 to 0.12, p=0.002). Therefore, long-acting GnRHa therapy may improve LBR.
fresh ET and FET cycles

Subgroup comparisons of adenomyosis population in
fresh embryo transfer cycles
BMJ Open 2024;14:e077025.
doi:10.1136/bmjopen-2023-077025
Because of the intragroup heterogeneity in LBR, we made sensitivity analysis and the results
indicated that the benefit of ultralong protocol on LBR (3 studies, 1202 women, 46.04% vs 36.93%,
OR: 1.40, 95% CI: 1.06 to 1.86, p=0.02).
Ultralong protocol may be beneficial for fresh ET cycles.

Subgroup comparisons of adenomyosis population in
frozen embryo transfer cycles
BMJ Open 2024;14:e077025.
doi:10.1136/bmjopen-2023-077025
LBR with long-acting GnRHa pretreatment seemed higher than those without GnRHa pretreatment; however,
no statistical differences were observed (28.57% vs 23.1%, OR: 1.25, 95% CI: 0.86 to 1.82, p=0.25)

Subgroup comparisons of adenomyosis population
between fresh and frozen embryo transfer cycles
BMJ Open 2024;14:e077025.
doi:10.1136/bmjopen-2023-077025
GnRHa pretreatment combined with FET appears to be more
attractive. (one study, 50.93% vs 33.91%, p=0.003)

Assisted reproduction technology (ART) outcomes in the
fresh and freeze-all groups
Fertil Steril 2024;121:460-9.
10.1016/j.fertnstert.2023.11.039

ART outcomes in the fresh and freeze-all groups in patients with
adenomyosis with and without associated endometriosis
Fertil Steril 2024;121:460-9.
10.1016/j.fertnstert.2023.11.039

RBMO VOLUME 38 ISSUE 1 2019
10.1016/j.rbmo.2018.09.014

European Journal of Obstetrics and Gynecology 271 (2022) 223–234
doi:10.1016/j.ejogrb.2022.02.026

Pregnancy outcomes of 1st frozen-thawed embryo
transfer cycles (FET)
Scientific Reports | (2023) 13:6741
doi: 10.1038/s41598-023-34045-7

Cumulative live birth rates per retrieval cycle
Scientific Reports | (2023) 13:6741
doi: 10.1038/s41598-023-34045-7

Studies on adenomyosis, endometriosis, and pregnancy outcomes
Scientific Reports | (2023) 13:6741
doi: 10.1038/s41598-023-34045-7

Impact of adenomyosis on in vitro fertilization outcomes
in women undergoing donor oocyte transfers
Fertil Steril 2024;121:480-8.
10.1016/j.fertnstert.2023.11.034

Pregnancy outcomes with donor oocyte embryos in
patients diagnosed with adenomyosis
Fertil Steril 2023;119:484-9
doi:10.1016/j.fertnstert.2022.12.021

Association between uterine volume and pregnancy outcomes in
adenomyosis patients undergoing frozen-thawed embryo transfer
RBMO VOLUME 42 ISSUE 2 2021
doi:10.1016/j.rbmo.2020.10.002
Group A,
uterine volume
≤98.81 cm3
Group B,
uterine volume
>98.81 cm3

Clinical outcomes of initiated stimulation cycles by
presence of sonographic evidence of adenomyosis -SEOA
Human Reproduction Open, 2021
doi:10.1093/hropen/hoab015

Comparison of outcomes of fresh and frozen embryo
transfers by presence of sonographic evidence of
adenomyosis - SEOA
Human Reproduction Open, 2021
doi:10.1093/hropen/hoab015

Take Home Messages -1
Endometriosis
1.Endometriosis is unremarkable to ovarian response.
A reduction in the response to ovarian stimulation can be detected only for
endometriomas larger than 4 cm. The follicular steroidogenesis is unaffected.
2.Oocyte quality is preserved.
Fertilization rate is similar, making ICSI unjustifiable. Embryological development
does not differ from other forms of infertility, with no surge in aneuploidy rate.
3. Endometrial receptivity is not or minimally reduced.
To note, the most informative studies supporting this perspective did not exclude
women with adenomyosis, a main confounder that was expected to lower the
success of the procedure. This further strengthens the idea that women with
endometriosis should not be considered at increased risk of implantation
failure

Reproductive Biology and Endocrinology (2023) 21:107
doi: 10.1186/s12958-023-01157-8

Take Home Messages -2
Endometriosis
4.Encourage fertility preservation, particularly when
endometriomas are present.
5.Pre-treatment with GnRH agonists is not recommended to
improve outcomes in fertility treatments.
6.Stimulation protocols with GnRH antagonists are preferred.
7.When no fresh transfer is planned, it’s advisable to consider using
PPOS as a pituitary suppressor, especially if PPOS are used just
before stimulation to control symptoms of endometriosis.
Best Practice & Research Clinical Obstetrics & Gynaecology 92 (2024) 102429 .
doi. 10.1016/j.bpobgyn.2023.102429

Take Home Messages -3
Adenomyosis
1.The principal problem is related to the heterogenity of the patients with different
degrees of the disease, and patients with focal and diffuse adenomyosis were often
included in the same group.
2.An ultralong protocol is usually used in patients with adenomyosis and good ovarian
function. In fresh ET cycles, the ultralong protocol seemed to improve pregnancy
outcomes; however, increased gonadotropin duration and dosage increased the
economic burden.
3.In patients with poor ovarian function, an ultralong protocol should be adopted with
caution.
4.Long/short/antagonist protocols in fresh ET cycles combined with
a flexible FET strategy might be a viable choice for patients with
adenomyosis and poor ovarian reserve
Reproductive Sciences (2022) 29:3177–3193
BMJ Open 2024;14:e077025. doi: 10.1136/bmjopen-2023-077025

Thank you for your attention.

[email protected]
TevfikYoldemirMDBBAM profdrtevfikyoldemir Tevfik-
Yoldemir
profdr.tevfikyoldemir